(1)
Lebwohl, M.; Warren, R. B. .; Imafuku, S.; Bagel, J. .; Armstrong, A. W. .; Passeron, T.; Banerjee, S.; Kisa, R. M.; Vritzali, E. .; Colombo, M. J.; Scharnitz, T.; Hoyt, K.; Thaçi, D.; Blauvelt, A. Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-Year Results from the POETYK PSO Program. J of Skin 2024, 8, s365.